Regional Citrate Anticoagulation for PrismaFlex Continuous Renal Replacement Therapy
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2009 |
|---|---|
| Erschienen: |
2009 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
The annals of pharmacotherapy - 43(2009), 9, Seite 1419-1425 |
| Beteiligte Personen: |
Burry, Lisa D. [VerfasserIn] |
|---|
| BKL: |
|---|
| Umfang: |
7 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1827205741 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1827205741 | ||
| 003 | DE-627 | ||
| 005 | 20230518182711.0 | ||
| 007 | tu | ||
| 008 | 091001s2009 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw091001 |
| 035 | |a (DE-627)OLC1827205741 | ||
| 035 | |a (DE-599)GBVOLC1827205741 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Burry, Lisa D. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Regional Citrate Anticoagulation for PrismaFlex Continuous Renal Replacement Therapy |
| 264 | 1 | |c 2009 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Tung, David D. |4 oth | |
| 700 | 1 | |a Hallett, David |4 oth | |
| 700 | 1 | |a Bailie, Toni |4 oth | |
| 700 | 1 | |a Carvalhana, Virginia |4 oth | |
| 700 | 1 | |a Lee, David |4 oth | |
| 700 | 1 | |a Ramganesh, Steve |4 oth | |
| 700 | 1 | |a Richardson, Robert |4 oth | |
| 700 | 1 | |a Mehta, Sangeeta |4 oth | |
| 700 | 1 | |a Lapinsky, Stephen E. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t The annals of pharmacotherapy |d Thousand Oaks, Calif. : Sage, 1992 |g 43(2009), 9, Seite 1419-1425 |w (DE-627)131046314 |w (DE-600)1101370-9 |w (DE-576)029155746 |x 1060-0280 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2009 |g number:9 |g pages:1419-1425 |g extent:7 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_2002 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 43 |j 2009 |e 9 |h 1419-1425 |g 7 | ||